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Disruption of ALX1 Causes Extreme Microphthalmia
and Severe Facial Clefting: Expanding the Spectrum of
Autosomal-Recessive ALX-Related Frontonasal Dysplasia
Elif Uz,1,13 Yasemin Alanay,2,13 Dilek Aktas,1,2 Ibrahim Vargel,3,4 Safak Gucer,5 Gokhan Tuncbilek,4
Ferdinand von Eggeling,6 Engin Yilmaz,7 Ozgur Deren,8 Nicole Posorski,6 Hilal Ozdag,9 Thomas Liehr,6
Sevim Balci,2 Mehmet Alikasifoglu,1,2 Bernd Wollnik,10,11,12 and Nurten A. Akarsu1,*
We present an autosomal-recessive frontonasal dysplasia (FND) characterized by bilateral extreme microphthalmia, bilateral oblique
facial cleft, complete cleft palate, hypertelorism, wide nasal bridge with hypoplasia of the ala nasi, and low-set, posteriorly rotated
ears in two distinct families. Using Affymetrix 250K SNP array genotyping and homozygosity mapping, we mapped this clinical entity
to chromosome 12q21. In one of the families, three siblings were affected, and CNVanalysis of the critical region showed a homozygous
3.7 Mb deletion containing the ALX1 (CART1) gene, which encodes the aristaless-like homeobox 1 transcription factor. In the second
family we identiﬁed a homozygous donor-splice-site mutation (c.531þ1G> A) in the ALX1 gene, providing evidence that complete loss
of function of ALX1 protein causes severe disruption of early craniofacial development. Unlike loss of its murine ortholog, loss of human
ALX1 does not result in neural-tube defects; however, it does severely affect the orchestrated fusion between frontonasal, nasomedial,
nasolateral, and maxillary processes during early-stage embryogenesis. This study further expands the spectrum of the recently recog-
nized autosomal-recessive ALX-related FND phenotype in humans.Frontonasal dysplasia (FND [MIM 136760]), or median
facial cleft, is a remarkable outcome of developmental
failure of the facial prominences surrounding the primitive
mouth. Incompletemigrationof theorbits into their proper
positions results in various degrees of hypertelorism and
causes a spectrum of malformations. Hypertelorism is
frequently associatedwith cranial, cerebral, limb, and other
abnormalities. Facial ﬁndings range from mild hypertelor-
ism to severemidline clefts of the nose, lip, palate, and fore-
head. The nosology of this group ofmalformations remains
unclear. Differentiation of the phenotypes of this spectrum
isusually basedon thepresenceof associatedorgan involve-
ment rather than on overlapping facial ﬁndings.1–9 Auto-
somal-recessive frontofacionasal dysplasia (FFND [MIM
229400]), reported and named by Gollop, is the most
severe form of frontonasal dysplasia.10 Cardinal clinical
characteristics are midline facial defects, telecanthus, and
eyelid malformation;10 however, extreme variability in the
severity of abnormalities and associated ﬁndings, includ-
ing anophthalmia and severe bilateral clefting, has been
described.11
Genetic aspects of FND are not well deﬁned. The mode
of inheritance is unclear in the majority of cases presented
in the literature. Until recently, mutation in the gene
encoding the ephrin receptor tyrosine kinase 1 (EFNB11Gene Mapping Laboratory, Department of Medical Genetics, Hacettepe Univ
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The Ame[MIM 300035]), responsible for X-linked craniofrontonasal
syndrome (CFNS [MIM 304110]), was the only known
molecular cause.12,13 Two recent studies have drawn atten-
tion to the critical role of aristaless-related homeobox
transcription factors (ALX3 [MIM 606014]) and (ALX4
[MIM 605420]) during craniofacial development, particu-
larly in the molecular pathogenesis of frontonasal dys-
plasia in humans.14,15 Aristaless-like homeobox genes
Alx1 (Cart1), Alx3, and Alx4 encode paired-type homeodo-
main proteins, which are thought to play an important
role in the development of structures derived from cranio-
facial mesenchyme, the ﬁrst branchial arch, and the limb
bud.16 The fourth member of the vertebrate Alx gene
family, which should be named as ‘‘Alx2,’’ has not been
reported (P. Holland and T. Takahashi, personal communi-
cation).17 Although both heterozygous and homozygous
Alx3 knockout mice do not show an obvious phenotype,
homozygous ALX3 mutations in humans cause a distinc-
tive presentation of frontonasal dysplasia, namely fronto-
rhiny (FND [MIM 136760]).14 A large case-control study
of facial clefts further suggested that common variants
in ALX3 might have a role in isolated clefting.18 We
recently demonstrated that homozygous mutations in
the ALX4 gene cause a new frontonasal dysplasia pheno-
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Figure 1. Clinical Presentation and Molecular Findings of Family 1
Pedigree of Family 1
(A–F) Identical facial appearance and caudal appendage in affected siblings.
(G–H) Brachycephaly, bilateral extreme microphtalmia, and a large midline bone defect of the cranium.
(I) Schematic representation of homozygosity data of the chromosome 12q21.3 region. Genotype ﬁles (CHP ﬁles) were generated with
Affymetrix GTYPE software andwere transferred to the VIGENOS (Visual Genome Studio) program (Hemosoft, Ankara), which facilitates
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Heterozygous ALX4 mutations have been described in
patients with parietal foramina of the skull (FPM [MIM
168500]), without facial involvement. The nasal conﬁgura-
tions of recessive ALX3- and ALX4-related frontonasal
dysplasias are strikingly similar, despite the diversity of
associated ﬁndings. Human mutations in aristaless-like
homeobox gene 1 (CART1) (ALX1 [MIM 601527]) have
not yet been reported.
We identiﬁed a Turkish patient who had severe frontofa-
cionasal dysplasia and was born to consanguineous par-
ents (family 1) (Figures 1A–1H). The affected male patient
is currently 11 years old. The craniofacial features noted
at birth included hypertelorism, bilateral extreme micro-
phtalmia, upper eyelid colobomata, sparse eyelashes,
absence of eyebrows, wide nasal base, hypoplasia of the
ala nasi, bilateral nonmidline cleft lip with a prominent
glabella, complete cleft palate, and low-set posteriorly
rotated ears (Figure 1A, individual P1). The only extracra-
nial ﬁnding was the presence of a caudal appendage in
the sacral region (Figure 1B). Mild dilatation of the collect-
ing system was observed with renal ultrasound. Orbital
and brain MRI showed brachycephaly, bilateral extreme
microphtalmia, and a large midline bone defect of the
cranium (Figures 1G–1H). Karyotype analysis was normal.
At present, the patient has mild mental retardation, neces-
sitating special education. He follows commands very well,
and his hearing is normal; however, his facial anatomy
currently prevents sufﬁcient expressive speech, and he is
only able to say mama. Motor developmental milestones
were surprisingly normal; he began to walk at 12 months.
Themother had two consecutive pregnancies with affected
fetuses that had an identical phenotype and were diag-
nosed prenatally (Figure 1, fetuses P2 and P3). The second
pregnancy was terminated at the 25th week of gestation
after prenatal ultrasound detected the craniofacial pheno-
type. Fetal autopsy revealed identical craniofacial ﬁndings,
including bilateral extreme microphtalmia, bilateral non-
midline cleft lip, prominent glabella, and complete cleft
palate (Figure 1C). A caudal appendage was also present
in the sacral region, but there was no vertebral defect
(Figure 1D). Examination of the central nervous system
showed asymmetric optic nerves, agenesis of the corpus
callosum, and mild cerebellar hypoplasia. Intra-abdominal
organs were morphologically normal. Histological exami-visualization of a large amount of genome data in comprehensible v
data obtained from the index case (affected individual P1, family 1)
in white, whereas heterozygous SNPs appear in orange. Noninformati
indicated in yellow. Gray: no call; F: father; M: mother; P1-3: patients
approximately 27Mb in size. TheMendelian segregation error spanne
is marked in brackets.
(J) Diagrams obtained with CNAG software (blue and red arrows show
siblings, respectively).
(K) Results of array-CGH analysis of chromosome 12 obtained from t
The raw data (tiff images) were extracted with Feature Extraction soft
were analyzedwith CGHAnalytics software v.3.5.14 (Agilent Technol
interest showing a copy-number change on 12q21.31 is indicated abo
ning 81.9–85.6 Mb is marked by the blue block. Seven genes (TMTC2
are located within this 3.7 Mb region.
The Amenation detected small cystic dilatations in the renal collect-
ing system. The third pregnancy was terminated at the
23rd week of gestation (Figure 1, fetus P3). Fetal autopsy
revealed similar craniofacial ﬁndings (Figures 1E–1F).
Examination of the central nervous system showed corpus
callosum agenesis, bilateral hypoplastic optic nerves, and
neuronal heterotopia of the pons. Histological evaluation
of the renal system revealed a signiﬁcant delay in matura-
tion, despite macroscopically normal kidneys. The study
protocol was approved by the Hacettepe University Medi-
cal Faculty Ethics Committee (TBK 09/4-42). DNA samples
were obtained after written consent was secured from the
parents.
Genome-wide homozygosity mapping of both parents
and three affected siblings was carried out with GeneChip
mapping 250K SNP arrays from Affymetrix and revealed
a single large homozygous stretch spanning approximately
27 Mb on chromosome 12q21.3 (Figure 1I). Interestingly,
a Mendelian segregation error spanning between 81.9
and 85.6 Mb (approximaely 3.7 Mb) was detected within
this homozygous stretch (Figure 1I). Analysis of the SNP
array data by CNAG (Copy number analyzer for GeneChip
v. 2.0, updated for the analysis of 500K SNP arrays19)
showed a homozygous deletion of the entire region in all
affected offspring (Figure 1J). The healthy parents were
heterozygous carriers of this deletion. Cranial CT scans of
both parents did not detect any abnormalities. The chro-
mosomal imbalance was further conﬁrmed by an indepen-
dent method involving high-resolution Agilent array CGH
(microarray-based comparative genomic hybridization)
(Figure 1K). An array-CGH experiment was performed
with the Human Genome Microarray Kit 105A (Agilent
Technologies, Santa Clara, CA, USA). Seven genes (TMTC2,
SLC6A15 [MIM 607971]), LRRIQ1, ALX1 (CART1), PAMCI
[MIM 610383], NTS [MIM 162650], and MGAT4C [MIM
607385]) were located in the deleted region. The human
ortholog of mouse aristaless-like homeobox 1 gene, ALX1
(CART1), was a highly relevant candidate gene potentially
responsible for the craniofacial phenotype; homozygous
Alx1 knockout mice exhibit large cranial defects and a
lack of brain tissue.20,21
We expanded our study to include another Turkish
patient with an almost identical phenotype from a family
unrelated to that of the ﬁrst patient. The affected girl wasisual screens.15 Homozygous genotypes identical to the genotype
are shown in blue. Contrasting homozygote genotypes are shown
veness as a result of heterozygous genotypes in parent-child trios is
1–3. The overlapping homozygous stretches of three patients are
d a 3.7 Mb region (between 81.924.095 and 85.661.618 bases) and
single- and double-copy deletions observed in parents and affected
he Agilent Platform (Agilent Technologies, Santa Clara, CA, USA).
ware v.10.5.1.1. (Agilent Technologies, Santa Clara, CA, USA) and
ogies, Santa Clara, CA, USA). In the chromosome view the region of
ve the ideogram by a black rectangle. The observed deletion span-
, SLC6A15, LRRIQ1, CART1 (¼ ALX1), PAMCI, NTS, andMGAT4C)
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Figure 2. Clinical and Molecular Findings of Family 2
(A–C) Pedigree and clinical and radiological presentation of the patient in family 2.
(D) Identiﬁcation of the homozygous donor splice-site mutation. The upper panel shows the sequence chromatogram of the index
patient carrying the homozygous c.531þ1G > A mutation. The dotted line represents the border between exon 2 and intron 2 of the
ALX1 gene in humans. The position of domains andmotifs of human ALX1was obtained from the Uniprot database (Uniprot accession
number Q15699). The amino acid sequence alignment of the homeodomains of ALX family proteins are shown in the lower panel. At
the protein level, the splice site mutation targets the glutamine residue at position 177 (marked in bold) in helix III of the ALX1 homeo-
domain. The residues 76–177 containing a gross part of the homeodomain are encoded by exon 2. The amino acid sequence following
the splice site mutation is shown in gray and is marked with a dotted arrow. The highly conserved homeodomain as well as the subse-
quent C-terminal parts of the protein will be affected by the splice-site mutation through different mechanisms.the ﬁrst child of a nonconsanguineous couple with a nega-
tive family history. However, both parents originated from
nearby villages in the same city, which suggested a recessive
etiology. Her primary manifestations were hypertelorism,
extreme microphtalmia on the right side, microphthalmia
of the left eye, upper eyelid colobomata, lack of eyelashes
and eyebrows, and palpable midline cranial cleft with a
soft tissue mass in the left frontal area (Figure 2A). A wide
nasal bridge with hypoplasia of the ala nasi, bilateral
nonmidlinecleft lip, veryprominentglabella, complete cleft
palate, and low-set posteriorly rotated earswerenoted. Brain
MRI at 4 months of age showed severely delayedmyeliniza-
tion, a thin corpus callosum, and asymmetric cerebellar
vermis conﬁguration on the left side. Three-dimensional
cranial CT imaging (Figures 2B and 2C) demonstrated
cranium biﬁdum and facial cleft, right occipital plagioce-
phaly, and right extreme microphthalmia. The left bulbus
oculiwasnormal in size; however, both eyes hadmillimetric792 The American Journal of Human Genetics 86, 789–796, May 14,cystic lesions in the anterior chamber andmicrocalciﬁcation
of the sclerae. The soft tissue mass in the left frontal area
suggested a dermoid cyst or a ﬁbroma. Abdominal, renal
ultrasound, and transthoracic echocardiography were nor-
mal. Aperipheral bloodkaryotypewasnormal.Motor devel-
opment was delayed. She underwent reconstructive surgery
but died in infancy because of a pulmonary infection.
In addition to other homozygous stretches throughout
the genome, 250K Affymetrix SNP array analysis of the
affected child identiﬁed homozygosity at the ALX1 region
on chromosome 12q21. Analysis of 250K array data indi-
cated that the affected child inherited regions identical
by descent in approximately 5% (1/20) of her genome
through both parents, which supports consanguinity
between parents. CNVanalysis did not show any structural
chromosomal anomalies. Considering the relatively low-
resolution proﬁle of the 250K array, we have performed a
higher-resolution analysis by using an Affymetrix 6.0 SNP2010
array; nevertheless, we did not detect any signiﬁcant chro-
mosomal imbalance throughout the genome, including
the chromosome 12q21 region. Sequencing of ALX1 (En-
sembl accession number ENST00000316824) showed
a homozygous G > A substitution at the invariant þ1 posi-
tion of the donor splice site of intron 2, c.531þ1G > A
(Figure 2D). The homozygous mutation was conﬁrmed
by an independent method—restriction-digestion analysis
with Hpy188III. The parents were heterozygous carriers,
and the mutation was not detected in 171 healthy Turkish
controls. The c.531þ1G > A mutation is predicted to
disrupt the donor site of ALX1 intron 2. RNA of the patient
was not available for further investigation of aberrant
ALX1 transcripts caused by the splice-site mutation. There-
fore, we can only speculate that the disruption of the
donor site could lead to complete skipping of exon 2,
encoding the majority of the homeodomain; complete
intron retention, causing frameshift and premature trun-
cation of the protein; or activation of a cryptic splice site
with an unknown effect on the protein. In any case, there
is a likely structural change of the mutant protein near the
glutamine residue at position 177 (Glu46) within the DNA
recognition helix (helix III) of the ALX1 homeodomain
(Figure 2D). The recognition helix is known to be crucial
for optimal DNA interactions with the major groove of
the target DNA.22 Thus, alterations or complete deletion
of this region most likely disrupts the DNA binding ability
of the protein. The molecular ﬁndings in this patient
further support the idea that likely loss of ALX1 function
is the underlying pathogenic mechanism for the new
FND phenotype presented in this study.
Alx1 (Cart1) plays a crucial role in the early phase of
chondrocyte development.23 Its expression is restricted
to forebrain mesenchyme, branchial arches, limb buds,
and cartilage.20,21 Zhao et al. reported that mice homozy-
gous for Alx1 null mutations have neural tube closure
defects that lead to anencephaly and acrania.21 Nasal carti-
lage was also severely affected, in addition to other facial
structures. The cranial neural-tube defect observed in
Alx1 mutant mice was prevented by prenatal administra-
tion of folic acid. Consequently, the authors suggested that
ALX1 is a candidate gene leading to defects in neural-tube
closure in humans.21
Neither cranial nor vertebral neural-tube closure defects
(such as spina biﬁda and/or anencephaly) were observed
in our affected patients. Although the caudal appendage
could be a sign of a hidden neural-tube closure defect,24
it was considered a vestigial human tail because there
were no bony structures inside the appendage and an
autopsy showed no evidence of spinal-cord anomalies.
The human embryo has a tail until the 6th–7th week of
gestation.25 This tail regresses, and caudal vertebrae fuse
to form the coccyx at the 7th–8th week of embryogenesis.
The nonvertebral apex remains temporarily and eventually
disappears. All true vestigial human tails reported in the
literature lack bone and cartilage and do not represent
abnormalities of the spinal cord.26 As such, we proposeThe Amethat, unlike Alx1-homozygous mutant mice, disruption
of ALX1 in humans does not lead to defects in neural-
tube closure.
The literature contains descriptions of at least 16
syndromes characterized by microphthalmia associated
with cleft lip and/or cleft palate.27 Because of the severity
of its expression and its recessive mode of inheritance,
the ALX1-related phenotype can be considered to be
borderline between autosomal-recessive frontofacionasal
dysplasia (FFND [MIM229400]) and Frynsmicrophthalmia
syndrome (anophthalmia plus syndrome [MIM 600776]).
Anophthalmia plus syndrome was ﬁrst reported in a pair
of siblings with bilateral anophthalmia, facial clefting,
microtia, large sacral neural-tube defects, and uterus
unicornis.28 Additional associatedﬁndings, suchas primary
congenital hypothyroidism (CHNG1 [MIM 275200] and
CHNG2 [MIM 218700]) and adrenal hypoplasia congenita
(AHC [MIM 300200]), were subsequently included in the
anophthalmia plus spectrum.29,30 Absence of the above
listed anomalies, as well as the absence of neural-tube
defects in our cases, clinically distinguishes the presented
phenotype fromanophthalmiaplus syndromeand suggests
a previously unrecognized phenotype, namely ALX1-
related FND, within the FFNDmalformation spectrum.
The new spectrum of ALX-related frontonasal dysplasias
(ALX-related FNDs) that involve loss-of-function muta-
tions in the ALX1, ALX3, and ALX4 genes provides insight
into the molecular basis of recessively inherited complex
frontonasal dysplasias. Figure 3 illustrates various stages
of facial development in relation to ALX-related FND
phenotypes. The human face originates from several
primordia in the 4th week of embryonic development.31
These primordia consist of a single frontonasal promi-
nence and paired nasomedial and nasolateral processes—
components of the nasal (olfactory) primordia and paired
maxillary and mandibular prominences—both of which
are components of the ﬁrst branchial arch.31 Morpholog-
ical evaluation of homozygous ALX3 and ALX4 loss-
of-function mutant phenotypes revealed embryonic dis-
ruption of the fusion of the frontal and medial nasal
prominences, which eventually led to biﬁd nose and
hypertelorism (Figure 3). A long philtrum and prominent
philtral ridges are characteristic of ALX3-related FND
(also known as frontorhiny), but not of the ALX4-related
FND facial phenotype.14,15 ALX4-related FND represents
a more severe manifestation, with remarkable hypertelor-
ism, additional eye involvement, blepharophimosis, and
total alopecia. Palate development seems to be normal
in both ALX3- and ALX4-related FNDs. Although facial
appearances in both ALX3- and ALX4-related FNDs
resemble those seen at approximately the tenth week of
human embryonic development, studies on Alx3/Alx4
double mutant mice demonstrated that apoptosis in the
frontonasal area could start much earlier than this, i.e., at
E10.0, which is equivalent to the 28th day in human
embryonic development.32 No palatal or tongue involve-
ment was observed in Alx3/Alx4 double mutant mice.32rican Journal of Human Genetics 86, 789–796, May 14, 2010 793
Figure 3. Morphological Comparison of ALX-Related FNDs
Facial and palate development are illustrated in the upper part of the ﬁgure. Regions of the human face that originate from various prom-
inences and palate development in two different stages are shown on the upper left and right, respectively. Palate development occurs
between the sixth and seventh week of embryonic development and originates from the median and paired lateral palatine processes
(upper right).31 During facial and palate development, the frontonasal prominence contributes to the formation of the bridge of the
nose; the lateral processes form the sides of the nose (alae). The merged nasomedial process is crucial to both nasal and palatal develop-
ment; it forms the intermaxillary segment, which is a precursor of the philtrum of the lip, the pre-maxillary component of the upper jaw,
and the primary palate. ALX1 expression is essential not only for building the oral and nasal cavities but also for proper eye development
during early embryogenesis. It is not possible to compensate for complete loss of ALX1 function, and frontonasal and palatal develop-
ment is likely to be disrupted in early stages of development. ALX4 and ALX3 expression are related more to regulating the formation of
the ﬁnal shape of the nose. TheALX4-related FNDphenotype ismore pronounced than that of ALX3-related FND in terms of the severity
of hypertelorism and eye involvement. Alopecia is also associated only with ALX4-related FND. A prominent philtral ridge is character-
istic of ALX3-related FNDs (frontorhiny).Obviously, the ALX1-related FND phenotype presents
the extreme end of developmental disruption and clinical
severity among the recessive ALX-related FNDs. Normal
development of structures originating from the frontal
and nasomedial prominences, such as the bridge of the
nose and the premaxillary component of the upper jaw,
respectively, is observed; however, bilateral oblique clefts
between premature medial and lateral structures indicate
disruption of the fusion of these structures, namely naso-
medial and nasolateral prominences. The absence of an
upper lip and macrostomia indicates that the nasomedial
and maxillary processes failed to fuse. If the medial and
lateral palatine processes do not fuse, it can result in
complete cleft palate. A lack of fusion of the apices of the
lateral palatine process (palatal shelves) in the midline
suggests that embryonic development might be disrupted
before the seventh week of gestation. However, studies
on homozygous Alx1(Cart1) mutant mice indicated that
disruption in facial development could be placed even
earlier.21 Histological defects in head mesenchyme are ﬁrst
observed at E9.0 (equivalent to day 24 in human develop-
ment) in Alx1(Cart1)mutant embyos.21 Alx1(Cart1) expres-794 The American Journal of Human Genetics 86, 789–796, May 14,sion in palate mesenchyme is clearly shown during rat
embryogenesis, although a potential role of this gene in
palate differentiation is still not well understood.20
Mandibular processes originating from the ﬁrst branchial
arch are not affected in the ALX-related FND spectrum.
In conclusion, the present study expands the spectrum
of the newly recognized autosomal-recessive ALX-related
FND phenotypes. The craniofacial ﬁndings in our patients
with ALX1-related FND indicate that ALX1 plays an
essential role in the orchestrated fusion of frontonasal,
nasomedial, nasolateral, and maxillary processes during
early-phase embryogenesis. Future research will probably
unravel the interaction or cascade of events that occur
between different ALX genes.Acknowledgments
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